American Vanguard Stock Earnings Reports

American Vanguard reported a solid start to 2026 with first quarter net sales of $124 million, up ~7% year-over-year driven primarily by U.S. crop (+17%) and specialty (+6%) sales, while international sales declined 7% due to timing in Brazil and India. Adjusted EBITDA rose sharply to $10.3 million (up ~245%) as gross margin improved to 31% (up 500 bps) from better product mix and factory efficiency. Management emphasized operational improvements: rationalizing manufacturing (shifting synthesis to Alabama and narrowing the L.A. facility), headcount and leadership upgrades, technology/system investments, and a renewed focus on new product development (targeting 50 launches over five years to reach $100 million of annualized revenue by 2030). The company completed a refinancing that replaced the revolver with term loans, resulting in higher reported total debt ($267M) but materially higher cash ($71M) and a focus on net debt (~$196M). Management reiterated 2026 guidance of $530–$550 million in sales and $44–$48 million of adjusted EBITDA, and set medium-term goals to exceed $600 million revenue by 2028, move to double-digit EBITDA margins in the near term and ~15% EBITDA margins across the cycle longer term. Key investor takeaways: improving margin profile and cost discipline are already delivering results, the company has liquidity and a new capital structure to support execution, growth depends on successful new product introductions and restoring working capital efficiency to reduce net debt over the next 2–2.5 years.